Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Clinical trial NCT04775745 · RECRUITING
Trial details
- NCT number
- NCT04775745
- Sponsor
- Newave Pharmaceutical Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2027-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.